ATE142695T1 - Leukämiehemmender faktor aus vieharten und seine verwendung zur verbesserung der implantation und der entwicklung von embryonalen zellen - Google Patents

Leukämiehemmender faktor aus vieharten und seine verwendung zur verbesserung der implantation und der entwicklung von embryonalen zellen

Info

Publication number
ATE142695T1
ATE142695T1 AT90901507T AT90901507T ATE142695T1 AT E142695 T1 ATE142695 T1 AT E142695T1 AT 90901507 T AT90901507 T AT 90901507T AT 90901507 T AT90901507 T AT 90901507T AT E142695 T1 ATE142695 T1 AT E142695T1
Authority
AT
Austria
Prior art keywords
development
leukemia
inhibiting factor
livestock species
embryonal cells
Prior art date
Application number
AT90901507T
Other languages
English (en)
Inventor
Nicholas Martin Gough
Tracey Ann Willson
Robert Frederick Seamark
Original Assignee
Amrad Corp Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amrad Corp Ltd filed Critical Amrad Corp Ltd
Application granted granted Critical
Publication of ATE142695T1 publication Critical patent/ATE142695T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5415—Leukaemia inhibitory factor [LIF]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0603—Embryonic cells ; Embryoid bodies
    • C12N5/0604—Whole embryos; Culture medium therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20—Cytokines; Chemokines
    • C12N2501/23—Interleukins [IL]
    • C12N2501/235—Leukemia inhibitory factor [LIF]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Developmental Biology & Embryology (AREA)
  • Wood Science & Technology (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT90901507T 1989-01-10 1990-01-09 Leukämiehemmender faktor aus vieharten und seine verwendung zur verbesserung der implantation und der entwicklung von embryonalen zellen ATE142695T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AUPJ222089 1989-01-10
AUPJ270689 1989-02-13
AUPJ486089 1989-06-23

Publications (1)

Publication Number Publication Date
ATE142695T1 true ATE142695T1 (de) 1996-09-15

Family

ID=27157475

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90901507T ATE142695T1 (de) 1989-01-10 1990-01-09 Leukämiehemmender faktor aus vieharten und seine verwendung zur verbesserung der implantation und der entwicklung von embryonalen zellen

Country Status (8)

Country Link
US (3) US5418159A (de)
EP (1) EP0453453B1 (de)
JP (1) JP2974760B2 (de)
AT (1) ATE142695T1 (de)
CA (1) CA2045126A1 (de)
DE (1) DE69028514T2 (de)
NZ (1) NZ232072A (de)
WO (1) WO1990008188A1 (de)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990008188A1 (en) * 1989-01-10 1990-07-26 Amrad Corporation Limited Leukaemia inhibitory factor from livestock species and use thereof to enhance implantation and development of embryonic cells
WO1992001040A1 (en) * 1990-07-09 1992-01-23 Amrad Corporation Limited Enhanced implantation, development and maintenance of embryos using leukaemia inhibitory factor
US5589582A (en) * 1992-10-27 1996-12-31 Biotransplant, Inc. Polynucleotides en coding porcine cytokines
US5849991A (en) 1994-01-27 1998-12-15 Bresatch Limited Mice homozygous for an inactivated α 1,3-galactosyl transferase gene
WO1995020661A1 (en) * 1994-01-27 1995-08-03 Bresatec Ltd. Materials and methods for management of hyperacute rejection in human xenotransplantation
CA2267220A1 (en) 1996-10-11 1998-04-23 The Texas A & M University System Methods for the generation of primordial germ cells and transgenic animal species
US6177545B1 (en) * 1997-09-02 2001-01-23 Insight Strategy & Marketing Ltd. Heparanase specific molecular probes and their use in research and medical applications
US20010006630A1 (en) * 1997-09-02 2001-07-05 Oron Yacoby-Zeevi Introducing a biological material into a patient
US20020088019A1 (en) * 1997-09-02 2002-07-04 Oron Yacoby-Zeevi Methods of and pharmaceutical compositions for improving implantation of embryos
US20040213789A1 (en) * 1997-09-02 2004-10-28 Oron Yacoby-Zeevi Heparanase activity neutralizing anti-heparanase monoclonal antibody and other anti-heparanase antibodies
US6699672B1 (en) 1997-09-02 2004-03-02 Insight Biopharmaceuticals Ltd. Heparanase specific molecular probes and their use research and medical applications
AUPP053197A0 (en) 1997-11-26 1997-12-18 Amrad Operations Pty. Limited Compositions
WO1999042122A1 (en) * 1998-02-19 1999-08-26 University Of Southern California Method of promoting embryonic stem cell proliferation
AU753197B2 (en) * 1998-07-06 2002-10-10 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The Compositions and methods for in vitro fertilization
US20030217375A1 (en) * 1998-08-31 2003-11-20 Eyal Zcharia Transgenic animals expressing heparanase and uses thereof
EP1157118A4 (de) * 1999-03-01 2002-07-17 Insight Strategy & Marketing POLYNUKLEOTID, DAS FüR EIN POLYPEPTID MIT HEPARANASE-AKTIVäT KODIERT, UND DESSEN EXPRESSION IN GENETISCH VERäNDERTEN ZELLEN
US6635802B1 (en) 2000-01-10 2003-10-21 The Texas A&M University System Nuclear transfer using cells cultured in serum starvation media containing apoptosis inhibitors
JP3723839B2 (ja) * 2001-06-07 2005-12-07 国立大学法人広島大学 ニワトリの白血病阻止因子（ｌｉｆ）、及びそれをコードする遺伝子
US6671189B2 (en) * 2001-11-09 2003-12-30 Minebea Co., Ltd. Power converter having primary and secondary side switches
GB0220145D0 (en) * 2002-08-30 2002-10-09 Thromb X Nv Novel compositions for the in vitro derivation and culture of embryonic stem (ES) cell lines with germline transmission capability
AU2002218893A1 (en) * 2001-12-21 2003-07-09 Thromb-X Nv Compositions for the in vitro derivation and culture of embryonic stem (es) cell lines with germline transmission capability
EP1458852B1 (de) * 2001-12-21 2011-03-09 ThromboGenics N.V. Zusammensetzungen für die in vitro herleitung und kultur embryonaler stammzellinien mit keimbahnübertragungsfähigkeit und für die kultur adulter stammzellen
WO2004108065A2 (en) * 2003-06-09 2004-12-16 Insight Biopharmaceuticals Ltd. Heparanase activity neutralizing anti- heparanase monoclonal antibody and other anti-heparanase antibodies
US7409963B2 (en) * 2004-11-05 2008-08-12 Go Papa, Lllp Corner molding and stop assembly for collapsible shelter
EP3354723B1 (de) 2005-08-29 2023-12-13 Technion Research & Development Foundation Ltd. Medien zur züchtung von stammzellen
EP3441459B1 (de) * 2006-08-02 2021-03-17 Technion Research & Development Foundation Limited Verfahren zur expansion embryonaler stammzellen in einer suspensionskultur
JPWO2011125948A1 (ja) 2010-04-02 2013-07-11 独立行政法人理化学研究所 Ｅｓ細胞の製造方法
US10271876B2 (en) 2011-11-23 2019-04-30 Mezadata Medical Ip Holding Llc Method of in vitro fertilization with delay of embryo transfer and use of peripheral blood mononuclear cells
MX385372B (es) 2015-03-23 2025-03-18 Evestra Inc Nuevos agentes citotóxicos que preferentemente se dirigen al factor inhibidor de leucemia (lif) para el tratamiento de malignidades y como nuevos agentes anticonceptivos

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3643746A1 (de) * 1986-12-20 1988-06-30 Stohrer Doduco Gmbh & Co Tauchverfahren und vorrichtung zum elektrolytischen beschichten von platten, insbesondere von elektrischen leiterplatten
AU609128B2 (en) * 1987-04-02 1991-04-26 Amrad Operations Pty. Limited Leukaemia-inhibitory factor
WO1989007135A1 (en) * 1988-01-29 1989-08-10 Granada Genetics, Inc. Bovine embryo in vitro culture
DE68928914T2 (de) * 1988-08-04 1999-09-09 Amrad Corp. Ltd. (in vitro)-vermehrung von embryonalen stammzellen unter verwendung von leukämie-inhibitionsfaktor (lif)
WO1990008188A1 (en) * 1989-01-10 1990-07-26 Amrad Corporation Limited Leukaemia inhibitory factor from livestock species and use thereof to enhance implantation and development of embryonic cells
WO1992001040A1 (en) * 1990-07-09 1992-01-23 Amrad Corporation Limited Enhanced implantation, development and maintenance of embryos using leukaemia inhibitory factor

Also Published As

Publication number Publication date
DE69028514D1 (de) 1996-10-17
US5962321A (en) 1999-10-05
EP0453453A1 (de) 1991-10-30
US5418159A (en) 1995-05-23
CA2045126A1 (en) 1990-07-11
NZ232072A (en) 1992-05-26
US5641676A (en) 1997-06-24
EP0453453B1 (de) 1996-09-11
JPH04502554A (ja) 1992-05-14
WO1990008188A1 (en) 1990-07-26
JP2974760B2 (ja) 1999-11-10
DE69028514T2 (de) 1997-02-20
EP0453453A4 (en) 1992-10-14

Similar Documents

Publication Publication Date Title
ATE142695T1 (de) Leukämiehemmender faktor aus vieharten und seine verwendung zur verbesserung der implantation und der entwicklung von embryonalen zellen
ATE207115T1 (de) Tierzellenkultur
DK720488D0 (da) Immunokompromitterede kimaerepattedyr og anvendelse heraf til fremstilling af celler og stoffer
ATE12255T1 (de) Verfahren zur herstellung von selbstreproduzierenden pankreatischen inseln aehnlichen strukturen von saeugetieren.
ES2120946T3 (es) Sistemas y medios de cultivo celular.
DE69027526D1 (de) Herstellung von proteinen mittels homologer rekombination
ATE175994T1 (de) (in vitro)-vermehrung von embryonalen stammzellen unter verwendung von leukämie-inhibitionsfaktor (lif)
DE69637656D1 (de) Methoden zur Züchtung von Tierzellen
NO20003424D0 (no) Kommersielt anvendelig kjønns-spesifikk inseminasjon av pattedyr
DE69231485D1 (de) Verwendung von porösem Calciumcarbonat als Trägermaterial für in vitro Zellkulturen.
Egloff et al. SIZE RELATIONS OF THE FILTERING AREA OF TWO DAPHNIA SPECIES 1
Richa et al. Introduction of human DNA into mouse eggs by injection of dissected chromosome fragments
Sayre A method for culturing a predaceous tardigrade on the nematode Panagrellus redivivus
Chan et al. Culture of erythropoietic cells from chick blastoderms
Ravindranath The hemocytes of an isopod Ligia exotica Roux
KIKKAWA BIOCHEMICAL GENETICS OF PROTEOLYTIC ENZYMES IN DROSOPHILA MELANOGASTER I. GENERAL CONSIDERATIONS
Fedoroff Tracing glial cell lineages by colony formation in primary cultures
Maruyama Two types of spike generation of human Auerbach's plexus cells in culture
Kaneko et al. Mitosis in beating cardiac muscle cells from newt embryos in vitro
Holeckova et al. Aging in cell and tissue culture
Kambysellis et al. In vitro development of insect cells: III. Effects of ecdysone on neonatal larval cells
DE3871530D1 (de) Vorrichtung zum kultivieren von ruhenden zellen in einem bioreaktor.
ATE97958T1 (de) Zellenzuchtverfahren fuer die produktion von aktiviertem protein-c.
ES381368A1 (es) Un metodo de cultivar un genero de celulas hepaticas epite-liales humanas heteroploides.
SU1520095A1 (ru) Питательна среда дл культивировани клеток человека и животных

Legal Events

Date Code Title Description
REN Ceased due to non-payment of the annual fee